Cargando…
CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
T cell chimeric antigen receptor (CAR) technology has allowed for the introduction of a high degree of tumor selectivity into adoptive cell transfer therapies. Evolution of this technology has produced a robust antitumor immunotherapeutic strategy that has resulted in dramatic outcomes in liquid can...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199385/ https://www.ncbi.nlm.nih.gov/pubmed/30386740 http://dx.doi.org/10.3389/fonc.2018.00453 |